Patients are embracing and exploring alternatives to the traditional office practice, and the expansion of retail health clinics is a big part of that. However, the American College of Physicians said these clinics are best used as a backup alternative to a primary care physician.
Patients are embracing and exploring alternatives to the traditional office practice, and the expansion of retail health clinics is a big part of that. However, the American College of Physicians (ACP) said these clinics are best used as a backup alternative to a primary care physician.
A new position paper from ACP offers recommendations and provides guidance to physicians and their patients in understanding the role retail health clinics should have in providing quick, convenient care.
“A balance must be struck between the convenience and easy access retail clinics provide with the importance of establishing relationships between patients and physicians, particularly for patients who have complex medical histories and/or multiple medical problems,” Wayne J. Riley, MD, MPH, MBA, MACP, president of ACP, said in a statement.
ACP offers 6 recommendations and positions:
“The positions put forward by ACP highlight a meaningful approach that will have positive effects for both patients and physicians,” Dr Riley said. “The health care system will, then, realize the full potential of primary care physicians working collaboratively with retail health clinics.”
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More